News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279,790 Results
Type
Article (11824)
Company Profile (75)
Press Release (267891)
Section
Business (90832)
Career Advice (735)
Deals (15931)
Drug Delivery (59)
Drug Development (21058)
Employer Resources (41)
FDA (5801)
Job Trends (7031)
News (137359)
Policy (13445)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
Academia (1158)
Accelerated approval (2)
Adcomms (10)
Allergies (44)
Alliances (26757)
ALS (18)
Alzheimer's disease (458)
Antibody-drug conjugate (ADC) (44)
Approvals (5807)
Artificial intelligence (114)
Autoimmune disease (9)
Automation (9)
Bankruptcy (122)
Best Places to Work (5983)
BIOSECURE Act (17)
Biosimilars (79)
Biotechnology (42)
Bladder cancer (30)
Brain cancer (8)
Breast cancer (92)
Cancer (767)
Cardiovascular disease (51)
Career advice (615)
Career pathing (9)
CAR-T (37)
Cell therapy (158)
Cervical cancer (9)
Clinical research (17126)
Collaboration (391)
Compensation (268)
Complete response letters (12)
COVID-19 (1019)
CRISPR (11)
C-suite (89)
Cystic fibrosis (19)
Data (691)
Decentralized trials (1)
Denatured (5)
Depression (10)
Diabetes (62)
Diagnostics (3505)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (50)
Drug pricing (73)
Drug shortages (5)
Duchenne muscular dystrophy (36)
Earnings (31215)
Editorial (11)
Employer branding (6)
Employer resources (33)
Events (33995)
Executive appointments (316)
FDA (6330)
Featured Employer (17)
Frontotemporal dementia (2)
Funding (285)
Gene editing (32)
Generative AI (9)
Gene therapy (119)
GLP-1 (208)
Government (2524)
Grass and pollen (3)
Guidances (30)
Healthcare (9770)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (40)
Indications (14)
Infectious disease (1083)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (27)
Intellectual property (24)
Interviews (112)
IPO (6804)
IRA (33)
Job creations (1231)
Job search strategy (533)
Kidney cancer (3)
Labor market (12)
Layoffs (126)
Leadership (2)
Legal (2378)
Liver cancer (20)
Lung cancer (120)
Lymphoma (46)
Management (10)
Manufacturing (185)
MASH (17)
Medical device (5775)
Medtech (5778)
Mergers & acquisitions (9407)
Metabolic disorders (152)
Multiple sclerosis (21)
NASH (5)
Neurodegenerative disease (24)
Neuropsychiatric disorders (4)
Neuroscience (580)
NextGen: Class of 2025 (3558)
Non-profit (2568)
Northern California (896)
Now hiring (13)
Obesity (59)
Opinion (80)
Ovarian cancer (26)
Pain (18)
Pancreatic cancer (21)
Parkinson's disease (25)
Partnered (14)
Patents (58)
Patient recruitment (32)
Peanut (26)
People (26791)
Pharmaceutical (21)
Pharmacy benefit managers (9)
Phase I (5307)
Phase II (7192)
Phase III (6181)
Pipeline (528)
Podcasts (16)
Policy (86)
Postmarket research (619)
Preclinical (2092)
Press Release (71)
Prostate cancer (36)
Psychedelics (14)
Radiopharmaceuticals (95)
Rare diseases (108)
Real estate (3587)
Recruiting (16)
Regulatory (9498)
Reports (18)
Research institute (1064)
Resumes & cover letters (107)
RNA editing (1)
RSV (14)
Schizophrenia (18)
Series A (43)
Series B (24)
Service/supplier (15)
Sickle cell disease (22)
Southern California (827)
Special edition (8)
Spinal muscular atrophy (32)
Sponsored (18)
Startups (1378)
State (1)
Stomach cancer (3)
Supply chain (34)
The Weekly (11)
United States (8677)
Vaccines (242)
Venture capitalists (6)
Webinars (3)
Weight loss (41)
Women's health (11)
Worklife (2)
Date
Today (62)
Last 7 days (310)
Last 30 days (1193)
Last 365 days (14014)
2025 (3510)
2024 (14634)
2023 (16700)
2022 (23982)
2021 (25337)
2020 (25304)
2019 (23983)
2018 (18171)
2017 (13655)
2016 (13153)
2015 (14730)
2014 (10513)
2013 (8804)
2012 (9579)
2011 (10155)
2010 (8710)
Location
Africa (302)
Alabama (23)
Alaska (5)
Arizona (71)
Arkansas (9)
Asia (15725)
Australia (1997)
California (2094)
Canada (991)
China (227)
Colorado (129)
Connecticut (95)
Delaware (63)
Europe (36420)
Florida (334)
Georgia (66)
Hawaii (1)
Idaho (28)
Illinois (261)
India (15)
Indiana (115)
Iowa (3)
Japan (64)
Kansas (31)
Kentucky (20)
Louisiana (6)
Maine (30)
Maryland (448)
Massachusetts (1481)
Michigan (96)
Minnesota (135)
Mississippi (2)
Missouri (42)
Montana (11)
Nebraska (13)
Nevada (23)
New Hampshire (24)
New Jersey (746)
New Mexico (18)
New York (575)
North Carolina (522)
North Dakota (8)
Northern California (896)
Ohio (108)
Oklahoma (11)
Oregon (8)
Pennsylvania (558)
Puerto Rico (7)
Rhode Island (14)
South America (474)
South Carolina (5)
Southern California (827)
Tennessee (45)
Texas (345)
Utah (57)
Virginia (40)
Washington D.C. (23)
Washington State (169)
West Virginia (3)
Wisconsin (25)
279,790 Results for "scorpion biological services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Lilly Drops Up to $2.5B for Scorpion’s PI3K-inhibitor Molecule
The multi-billion deal, in which Eli Lilly will acquire Scorpion Therapeutics’ STX-478 program, is a shot in the arm for PI3K treatments, which have had a mixed history over the past few years.
January 13, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
January 14, 2025
·
6 min read
Lone Star Bio
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpion Biological Services announced it has changed its name to Scorpius BioManufacturing reflecting the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
December 20, 2022
·
2 min read
Press Releases
Scorpion Therapeutics Provides Clinical Program Updates for Its Mutant-Selective PI3Kα Inhibitor STX-478
December 10, 2024
·
6 min read
Business
Scorpion Biological Services Celebrates Grand Opening of its San Antonio Facility
Scorpion Biological Services, a fully integrated contract research and contract development & manufacturing organization focused on the development of biologic drugs, hosted the grand opening of its new, state-of-the-art San Antonio facility on Friday, October 21, 2022.
October 25, 2022
·
2 min read
Press Releases
Bionova Scientific Appoints Bionique Testing Laboratories as Preferred Provider for Mycoplasma Testing Services for Biologics Manufacturing
March 20, 2025
·
4 min read
Press Releases
Biological Safety Testing Services Market Size to Hit USD 10.82 Billion by 2034
February 18, 2025
·
1 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Business
Scorpion Therapeutics Appoints Precision Medicine Leader Jeff Albers as Strategic Advisor
Scorpion Therapeutics, Inc. today announced the appointment of Jeff Albers as a strategic advisor to the company.
October 24, 2023
·
3 min read
Business
NightHawk Biosciences Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services
NightHawk Biosciences announced the appointment of Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services.
June 13, 2022
·
5 min read
1 of 27,979
Next
